Toiber F, Murthy V S
Sinai Samaritan Medical Center, Milwaukee, WI 53201.
Hosp Formul. 1991 Oct;26(10):811-3, 817-8.
The prescribing and usage patterns of two antihypertensive agents, terazosin (Hytrin) and enalapril maleate (Vasotec) were analyzed and compared over a 6-month study period, using data from the PDS Alpha Data Base. The study analyzed several variables for both physician prescribing patterns and patient responses. Overall, the two agents performed equally well during the study period, with 6-month retention rates (% of patients who continued to take the same medication) of approximately 60%. Although both drugs are judged to be good candidates for first-line antihypertensive therapy, it was observed during the study that family practitioners write considerably more prescriptions for terazosin than enalapril, while internists write more enalapril prescriptions. We concluded that these differences in prescribing and usage patterns were largely attributable to the manufacturers' marketing strategies and to how various physicians perceive the two agents, rather than to actual clinical differences between them.
使用PDS Alpha数据库的数据,对两种抗高血压药物特拉唑嗪(海特舒)和马来酸依那普利(悦宁定)在6个月的研究期内的处方和使用模式进行了分析和比较。该研究分析了医生处方模式和患者反应的几个变量。总体而言,在研究期间这两种药物表现相当,6个月的留存率(继续服用同一种药物的患者百分比)约为60%。尽管两种药物都被认为是一线抗高血压治疗的良好选择,但在研究中观察到,家庭医生开具的特拉唑嗪处方比依那普利多得多,而内科医生开具的依那普利处方更多。我们得出结论,这些处方和使用模式的差异在很大程度上归因于制造商的营销策略以及不同医生对这两种药物的认知,而非它们之间实际的临床差异。